India?s Cipla to buy two U.S. generic drug firms for $550 million
 

India?s Cipla to buy two U.S. generic drug firms for $550 million
MUMBAI (Reuters) - India's Cipla Ltd said on Friday it has agreed to buy two generics businesses in the United States in an all-cash deals worth $550 million, as part of an effort to boost its...http://feeds.feedburner.com/~ff/news...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/news...IY:V_sGLiPBpWU http://feeds.feedburner.com/~ff/news...IY:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/news/...~4/nNdcz342VNc